Why Some People With Type 1 Diabetes Stay Protected From Heart and Kidney Disease

Cardiovascular disease—including heart disease and kidney damage—is the leading cause of serious illness and death in Type 1 diabetes. Yet something remarkable happens in some people: despite decades of high blood sugar and other risk factors, they remain free from these major complications. Researchers call these individuals 'Escapers,' and a new study set out to understand what makes them different.

The ESCAPER study compared two groups of people with Type 1 diabetes. One group had lived with diabetes for an average of 40 years without developing heart disease, kidney disease, or vision-threatening complications. The other group, called 'Rapid Progressors,' developed serious eye and kidney disease much earlier—within roughly 20 years—despite shorter disease duration.

Researchers analyzed 92 different proteins in the blood of both groups using a targeted technique called proteomics. This approach allowed them to create a detailed snapshot of biological differences between people who stayed protected and those who developed complications quickly.

Twenty proteins showed meaningful differences between the two groups. The most striking finding involved a protein called Caspase-3, which was significantly higher in Rapid Progressors. This protein is linked to cell death and tissue damage—a sign of ongoing stress in blood vessels and organs.

Rapid Progressors also had higher levels of several proteins involved in blood clotting and inflammation. These included Junctional Adhesion Molecule A, Glycoprotein VI, and P-Selectin—all molecules that help activate platelets and allow white blood cells to stick to blood vessel walls. When these processes become overactive, they can damage blood vessels and promote clot formation.

Two additional proteins, PECAM-1 and TNFRSF14, were also elevated in those with fast-progressing complications, pointing to broader problems with how blood vessels function and communicate with the immune system.

This research suggests that 'Escapers' may have fundamentally different biological responses to long-standing high blood sugar. Rather than developing unchecked inflammation and vessel damage, their bodies may be controlling these harmful processes more effectively.

Understanding these protein signatures could eventually help doctors identify which people with Type 1 diabetes face the highest risk of complications early on. This information might guide treatment decisions, allowing more aggressive intervention for those at greatest risk. However, the study was observational, meaning it identified associations rather than proving cause-and-effect. More research will be needed to confirm these findings and explore whether targeting these proteins could prevent or delay complications.

Source: Cardiovascular diabetology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.